Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PALFORZIA 300 MG POLVO ORAL EN SOBRE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PALFORZIA 300 MG POLVO ORAL EN SOBRE

Approved

STANDARD

PALFORZIA 300 MG POLVO ORAL EN SOBRE

Stallergenes🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 29, 2022
Approval ID: 451eb16c60acb652
Company: Stallergenes
Type: Standard

Approval Details

Approval Id: 451eb16c60acb652
Drug Cima Aemps Name: PALFORZIA 300 MG POLVO ORAL EN SOBRE
Register Number: 1201495012
Holder Company Name: Stallergenes
Marketing Company Name: Stallergenes
Holder Company Detail Path: /organization/stallergenes
Marketing Company Detail Path: /organization/stallergenes
Authorization Date: 2022-07-29
Dosage Form: POLVO ORAL EN SOBRE
Dose: 300 MG
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Stallergenes
Company Detail Path: /organization/stallergenes

Company Information

Pharmaceutical Company Name: STALLERGENES
Country Name: France
City Name: antony,ile de france,country_fr
Address: 6 RUE ALEXIS DE TOCQUEVILLE

Active Ingredients

CACAHUETE POLVO DESENGRASADO, SEMILLAS

600 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 29, 2022

Approval ID

451eb16c60acb652

Type

Standard

Back to CIMA-AEMPS Approvals